CRBU Caribou Biosciences, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 13, 2026
$1,22
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$1,2252-Wochen-Tief
$3,5452-Wochen-Hoch
Marktkapitalisierung (MRQ)
$129M
P/E (TTM)
-1.1
EPS (TTM)
$-1.08
Umsatz (TTM)
$10M
Ihre Abzeichen
52W-Spanne
$1–$4
Analystenbewertung
BUY
Kursziel
$12
P/E
-1.1
ROE
-78.3%
Nettogewinnmarge
-1030.4%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
CRBU Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$1.22
Marktkapitalisierung (MRQ)
$129M
P/E (TTM)
-1.1
EPS (TTM)
$-1.08
Umsatz (TTM)
$10M
ROE (TTM)
-78.3%
52W-Spanne
$1–$4
CRBU Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$11M2019-12-31 → 2025-12-31
EPS$-1.592021-12-31 → 2025-12-31
Freier Cashflow$-112M2021-12-31 → 2025-12-31
Nettogewinnmarge-1030.4%2021-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | CRBU | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -1.15-Jahres-Durchschnitt ≈-3.4 | ≈-3.4 | · | · | |
| P/S (TTM) | 12.95-Jahres-Durchschnitt ≈33.1 | ≈33.1 | 40.4 | Unterbewertet | |
| K/B (MRQ) | 1.35-Jahres-Durchschnitt ≈1.4 | ≈1.4 | 2.4 | Unterbewertet | |
| Kurs / FCF (TTM) | -1.45-Jahres-Durchschnitt ≈-7.5 | ≈-7.5 | · | · | |
| Kurs / Cashflow (TTM) | -1.45-Jahres-Durchschnitt ≈-8.0 | ≈-8.0 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 1.05-Jahres-Durchschnitt ≈1.4 | ≈1.4 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | CRBU | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -1090.9%5-Jahres-Durchschnitt ≈-959.8% | ≈-959.8% | -3077.6% | Spitzenklasse | |
| EBITDA-Marge (TTM) | -1065.1%5-Jahres-Durchschnitt ≈-939.0% | ≈-939.0% | -3077.6% | Spitzenklasse | |
| Pretax Margin (Vorgewinnmarge) | -1332.3%5-Jahres-Durchschnitt ≈-906.2% | ≈-906.2% | -3779.8% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | -1030.4%5-Jahres-Durchschnitt ≈-906.1% | ≈-906.1% | -3650.4% | Spitzenklasse | |
| ROA (TTM) | -56.9%5-Jahres-Durchschnitt ≈-35.7% | ≈-35.7% | -66.8% | Im Einklang | |
| ROE (TTM) | -78.3%5-Jahres-Durchschnitt ≈-46.8% | ≈-46.8% | -108.3% | Im Einklang | |
| ROIC | -121.0%5-Jahres-Durchschnitt ≈-54.2% | ≈-54.2% | -98.3% | Unterdurchschnittlich |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | CRBU | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 6.55-Jahres-Durchschnitt ≈9.8 | ≈9.8 | 4.2 | Starke Liquidität | |
| Quick Ratio | 0.55-Jahres-Durchschnitt ≈2.9 | ≈2.9 | 1.7 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | CRBU | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 11.7%5-Jahres-Durchschnitt ≈22.3% | ≈22.3% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -7.0%5-Jahres-Durchschnitt ≈11.7% | ≈11.7% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | -2.0% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | CRBU | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.05-Jahres-Durchschnitt ≈0.0 | ≈0.0 | 0.0 | Spitzenklasse | |
| Receivables Turnover (Forderungsumschlag) | 66.85-Jahres-Durchschnitt ≈69.5 | ≈69.5 | 4.7 | Spitzenklasse | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$115.0K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
5.8%
Nächster Bericht
Nov 09, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 13, 2026 | $-0.24 | $-0.32 | 25.7% |
| 31. März 2026 | $-0.26 | $-0.32 | 19.8% | |
| 31. Dezember 2025 | $-0.28 | $-0.32 | 11.4% | |
| 30. September 2025 | $-0.30 | $-0.37 | 18.4% | |
| 30. Juni 2025 | $-0.58 | $-0.40 | -45.1% | |
| 31. März 2025 | $-0.43 | $-0.45 | 4.7% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $11M | $10M | $34M | $14M | $10M | $12M | |
| R&D Expense | $109M | $130M | $112M | $82M | $52M | $34M | |
| SG&A Expense | $38M | $46M | $38M | $38M | $24M | $14M | |
| Operating Expenses | $160M | $177M | $151M | $120M | $77M | $48M | |
| Operating Income | $-148M | $-167M | $-116M | $-106M | $-67M | $-36M | |
| Interest Expense | · | · | · | · | $8.0K | $20.0K | |
| Other Non-op | $-331.0K | $18M | $14M | $7M | $377.0K | $-3.0K | |
| Pretax Income | $-149M | $-149M | $-102M | $-99M | $-67M | $-36M | |
| Income Tax | $-550.0K | $-9.0K | $193.0K | $70.0K | $321.0K | $-2M | |
| Net Income | $-148M | $-149M | $-102M | $-99M | $-67M | $-34M | |
| EPS (Basic) | $-1.59 | $-1.65 | $-1.38 | $-1.64 | $-2.11 | · | |
| EPS (Diluted) | $-1.59 | $-1.65 | $-1.38 | $-1.64 | $-2.11 | · | |
| Shares (Basic) | 93,389,283 | 90,317,925 | 73,807,597 | 60,801,133 | 31,663,243 | · | |
| Shares (Diluted) | 93,389,283 | 90,317,925 | 73,807,597 | 60,801,133 | 31,663,243 | · | |
| EBITDA | $-145M | $-163M | $-113M | $-105M | $-66M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $12M | $16M | $51M | $58M | $240M | $16M | |
| Short-term Investments | · | · | · | · | $135M | $0 | |
| Receivables | $69.0K | $265.0K | $148.0K | $202.0K | $1M | $150.0K | |
| Prepaid Expense | $3M | $7M | $6M | $8M | $7M | $3M | |
| Current Assets | $145M | $219M | $339M | $260M | $391M | $24M | |
| PP&E (Net) | $7M | $19M | $18M | $11M | $5M | $4M | |
| PP&E (Gross) | $20M | $32M | $27M | $16M | $9M | $7M | |
| Accum. Depreciation | $14M | $13M | $9M | $6M | $4M | $3M | |
| Other Non-current Assets | $2M | $6M | $2M | $2M | $975.0K | $612.0K | |
| Total Assets | $175M | $313M | $432M | $374M | $442M | $36M | |
| Accounts Payable | $6M | $2M | $3M | $1M | $4M | $3M | |
| Accrued Liabilities | $17M | $24M | $21M | $16M | $13M | $9M | |
| Current Liabilities | $25M | $31M | $28M | $28M | $26M | $12M | |
| Capital Leases | $26M | $25M | $26M | $27M | $0 | · | |
| Deferred Tax | $0 | $548.0K | $557.0K | $381.0K | $476.0K | $155.0K | |
| Total Liabilities | $53M | $60M | $64M | $73M | $55M | $18M | |
| Common Stock | $9.0K | $9.0K | $8.0K | $6.0K | $6.0K | $1.0K | |
| Paid-in Capital | $719M | $701M | $668M | $500M | $486M | $7M | |
| Retained Earnings | $-597M | $-448M | $-299M | $-197M | $-98M | $-31M | |
| AOCI | $103.0K | $255.0K | $30.0K | $-2M | $-135.0K | $0 | |
| Stockholders' Equity | $122M | $253M | $368M | $301M | $388M | $-23M | |
| Liabilities + Equity | $175M | $313M | $432M | $374M | $442M | $36M | |
| Shares Outstanding | 95,143,690 | 92,378,577 | 88,448,948 | 61,029,184 | 60,263,158 | 9,710,829 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $4M | $2M | $984.0K | $900.0K | |
| Stock-based Comp | $13M | $17M | $14M | $12M | $3M | $1M | |
| Deferred Tax | $-551.0K | $-10.0K | $178.0K | $-95.0K | $320.0K | $-919.0K | |
| Other Non-cash | $21M | $-10M | $-9M | $-5M | $30M | · | |
| Operating Cash Flow | $-111M | $-138M | $-93M | $-91M | $-33M | $-33M | |
| CapEx | $1M | $5M | $12M | $6M | $2M | $317.0K | |
| Investing Cash Flow | $102M | $87M | $-68M | $-93M | $-176M | $6M | |
| Stock Issued | $4M | $15M | $1M | $0 | · | · | |
| Net Stock Activity | $4M | $15M | $1M | · | · | · | |
| Financing Cash Flow | $5M | $17M | $154M | $2M | $433M | $2M | |
| Net Change in Cash | $-4M | $-35M | $-7M | $-182M | $225M | $-25M | |
| Taxes Paid | · | $0 | $170.0K | $0 | $11.0K | $21.0K | |
| Free Cash Flow | $-112M | $-143M | $-105M | $-97M | $-35M | · | |
| Levered FCF | · | · | · | · | $-35M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -1329.4% | -1667.2% | -336.6% | -768.2% | -697.8% | · | |
| Net Margin | -1327.4% | -1491.9% | -296.1% | -717.8% | -697.3% | · | |
| Pretax Margin | -1332.3% | -1492.0% | -295.5% | -717.3% | -693.9% | · | |
| EBITDA Margin | -1296.7% | -1627.9% | -326.4% | -756.5% | -687.6% | · | |
| ROA | -60.6% | -40.0% | -25.3% | -24.4% | -28.0% | · | |
| ROE | -102.8% | -55.8% | -26.6% | -31.8% | -16.9% | · | |
| ROIC | -121.0% | -65.9% | -31.6% | -35.4% | -17.3% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 5.7 | 7.2 | 12.0 | 9.3 | 15.1 | · | |
| Quick Ratio | 0.5 | 0.5 | 1.8 | 2.1 | 9.4 | · | |
| Interest Coverage | · | · | · | · | -8372.4 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | · | |
| Receivables Turnover | 66.8 | 48.4 | 197.0 | 20.4 | 14.7 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.28 | $2.74 | $4.17 | $4.93 | $6.44 | · | |
| Revenue / Share | $0.12 | $0.11 | $0.47 | $0.23 | · | · | |
| Cash Flow / Share | $-1.19 | $-1.53 | $-1.26 | $-1.50 | · | · | |
| Cash / Share | $0.13 | $0.18 | $0.58 | $0.96 | $3.99 | · | |
| EPS (TTM) | $-1.59 | $-1.65 | $-1.38 | $-1.64 | $-2.11 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.7% | -71.0% | 148.9% | 44.3% | -22.4% | · | |
| Revenue CAGR 3Y | -7.0% | 1.4% | 40.8% | · | · | · | |
| Revenue CAGR 5Y | -2.0% | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $11M | $10M | $34M | $14M | $10M | · | |
| Net Income TTM | $-148M | $-149M | $-102M | $-99M | $-67M | · | |
| Market Cap | $151M | $147M | $507M | $383M | $909M | · | |
| P/E | -1.0 | -1.0 | -4.2 | -3.8 | -7.2 | · | |
| P/S | 13.6 | 14.7 | 14.7 | 27.7 | 94.7 | · | |
| P/B | 1.2 | 0.6 | 1.4 | 1.3 | 2.3 | · | |
| P / Tangible Book | 1.2 | 0.6 | 1.4 | 1.3 | 2.3 | · | |
| P / Cash Flow | -1.4 | -1.1 | -5.4 | -4.2 | -28.0 | · | |
| P / FCF | -1.3 | -1.0 | -4.8 | -3.9 | -26.3 | · | |
| Earnings Yield | -100.0% | -103.8% | -24.1% | -26.1% | -14.0% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $2M | $4M | $2M | $3M | $2M | $2M | $2M | $3M | $2M | $4M | $24M | $4M | $4M | $4M | $3M | |
| R&D Expense | $19M | $21M | $24M | $22M | $28M | $36M | $30M | $30M | $35M | $34M | $31M | $29M | $27M | $26M | $26M | $20M | |
| SG&A Expense | $8M | $8M | $9M | $9M | $10M | $10M | $10M | $10M | $11M | $15M | $10M | $10M | $10M | $9M | $9M | $10M | |
| Operating Expenses | $27M | $29M | $32M | $32M | $50M | $45M | $41M | $40M | $47M | $48M | $41M | $38M | $37M | $35M | $34M | $30M | |
| Operating Income | $-25M | $-26M | $-28M | $-29M | $-48M | $-43M | $-39M | $-38M | $-44M | $-46M | $-37M | $-15M | $-33M | $-31M | $-31M | $-27M | |
| Other Non-op | $1M | $1M | $1M | $2M | $-7M | $3M | $3M | $4M | $6M | $5M | $3M | $5M | $3M | $3M | $4M | $-110.0K | |
| Income Tax | · | $0 | $-550.0K | $0 | · | $0 | $-9.0K | $0 | $0 | $0 | $193.0K | $0 | $0 | $0 | $70.0K | $0 | |
| Net Income | $-24M | $-25M | $-26M | $-28M | $-54M | $-40M | $-35M | $-35M | $-38M | $-41M | $-35M | $-10M | $-30M | $-28M | $-27M | $-27M | |
| EPS (Basic) | $-0.24 | $-0.26 | $-0.28 | $-0.30 | $-0.58 | $-0.43 | $-0.39 | $-0.38 | $-0.42 | $-0.46 | $-0.32 | $-0.12 | $-0.48 | $-0.46 | $-0.44 | $-0.44 | |
| EPS (Diluted) | $-0.24 | $-0.26 | $-0.28 | $-0.30 | $-0.58 | $-0.43 | $-0.39 | $-0.38 | $-0.42 | $-0.46 | $-0.32 | $-0.12 | $-0.48 | $-0.46 | $-0.44 | $-0.44 | |
| Shares (Basic) | 100,985,698 | 95,861,716 | · | 93,293,099 | 93,028,698 | 92,679,493 | · | 90,455,900 | 90,340,932 | 89,302,937 | · | 83,783,992 | 61,417,934 | 61,186,514 | · | 60,886,921 | |
| Shares (Diluted) | 100,985,698 | 95,861,716 | · | 93,293,099 | 93,028,698 | 92,679,493 | · | 90,455,900 | 90,340,932 | 89,302,937 | · | 83,783,992 | 61,417,934 | 61,186,514 | · | 60,886,921 | |
| EBITDA | $-25M | $-26M | · | $-29M | $-48M | $-42M | · | $-38M | $-44M | $-45M | · | $-15M | · | · | · | $-27M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $26M | $12M | $12M | $11M | $25M | $29M | $16M | $32M | $38M | $49M | $51M | $104M | $66M | $53M | $58M | $82M | |
| Receivables | $203.0K | $227.0K | $69.0K | $242.0K | $71.0K | $88.0K | $265.0K | $184.0K | $215.0K | $917.0K | $148.0K | $1M | $766.0K | $2M | $202.0K | $397.0K | |
| Prepaid Expense | $2M | $2M | $3M | $5M | $6M | $6M | $7M | $7M | $6M | $7M | $6M | $7M | $6M | $6M | $8M | $9M | |
| Current Assets | $117M | $122M | $145M | $156M | $193M | $217M | $219M | $237M | $271M | $305M | $339M | $351M | $269M | $239M | $260M | $307M | |
| PP&E (Net) | $5M | $6M | $7M | $8M | $8M | $19M | $19M | $20M | $20M | $19M | $18M | $17M | $15M | $13M | $11M | $9M | |
| PP&E (Gross) | $20M | $20M | $20M | $20M | $20M | $33M | $32M | $31M | $31M | $29M | $27M | $25M | $22M | $19M | $16M | $14M | |
| Accum. Depreciation | $15M | $14M | $14M | $13M | $12M | $14M | $13M | $12M | $11M | $10M | $9M | $8M | $7M | $6M | $6M | $5M | |
| Other Non-current Assets | $2M | $2M | $2M | $4M | $4M | $5M | $6M | $5M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $1M | |
| Total Assets | $143M | $149M | $175M | $195M | $221M | $274M | $313M | $344M | $373M | $407M | $432M | $458M | $350M | $347M | $374M | $399M | |
| Accounts Payable | $3M | $4M | $6M | $4M | $3M | $4M | $2M | $3M | $3M | $6M | $3M | $2M | $4M | $3M | $1M | $1M | |
| Accrued Liabilities | $13M | $14M | $17M | $19M | $21M | $20M | $24M | $25M | $24M | $19M | $21M | $18M | $16M | $13M | $16M | $15M | |
| Current Liabilities | $18M | $20M | $25M | $28M | $29M | $28M | $31M | $32M | $31M | $29M | $28M | $25M | $34M | $27M | $28M | $29M | |
| Capital Leases | $25M | $26M | $26M | $23M | $24M | $24M | $25M | $25M | $26M | $26M | $26M | $26M | $26M | $26M | $27M | $27M | |
| Deferred Tax | · | · | $0 | $548.0K | $548.0K | $548.0K | $548.0K | $557.0K | $557.0K | $556.0K | $557.0K | $381.0K | $380.0K | $382.0K | $381.0K | $475.0K | |
| Total Liabilities | $45M | $47M | $53M | $53M | $55M | $56M | $60M | $63M | $62M | $64M | $64M | $59M | $80M | $69M | $73M | $75M | |
| Common Stock | $11.0K | $10.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Paid-in Capital | $744M | $724M | $719M | $712M | $709M | $705M | $701M | $693M | $689M | $684M | $668M | $664M | $525M | $504M | $500M | $496M | |
| Retained Earnings | $-646M | $-622M | $-597M | $-570M | $-542M | $-488M | $-448M | $-413M | $-378M | $-341M | $-299M | $-265M | $-255M | $-225M | $-197M | $-170M | |
| AOCI | $-71.0K | $-23.0K | $103.0K | $93.0K | $40.0K | $167.0K | $255.0K | $789.0K | $-319.0K | $-322.0K | $30.0K | $-981.0K | $-1M | $-730.0K | $-2M | $-2M | |
| Stockholders' Equity | $98M | $102M | $122M | $142M | $166M | $217M | $253M | $281M | $310M | $343M | $368M | $398M | $269M | $278M | $301M | $324M | |
| Liabilities + Equity | $143M | $149M | $175M | $195M | $221M | $274M | $313M | $344M | $373M | $407M | $432M | $458M | $350M | $347M | $374M | $399M | |
| Shares Outstanding | 105,995,653 | 96,951,234 | 95,143,690 | 93,468,038 | 93,123,239 | 93,004,602 | 92,378,577 | 90,552,687 | 90,362,771 | 90,314,501 | 88,448,948 | 88,430,609 | 66,100,039 | 61,323,523 | 61,029,184 | 60,986,936 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $625.0K | $649.0K | $682.0K | $631.0K | $1M | $1M | $1M | $1M | $856.0K | $710.0K | $740.0K | $2M | $617.0K | $589.0K | $506.0K | $450.0K | |
| Stock-based Comp | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $4M | $4M | $3M | $4M | $3M | $3M | $3M | |
| Restructuring | · | · | · | · | · | · | · | $600.0K | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-5M | · | · | · | $-2M | · | · | · | $-667.0K | · | · | · | · | · | · | |
| Operating Cash Flow | $-23M | $-27M | $-21M | $-25M | $-28M | $-37M | $-35M | $-33M | $-33M | $-37M | $-21M | $-29M | $-15M | $-28M | $-25M | $-22M | |
| CapEx | $1.0K | $72.0K | $-216.0K | $115.0K | $418.0K | $1M | $518.0K | $673.0K | $2M | $1M | $2M | $5M | $3M | $2M | $2M | $1M | |
| Investing Cash Flow | $19M | $24M | $18M | $11M | $24M | $49M | $16M | $27M | $21M | $23M | $-31M | $-68M | $11M | $21M | $1M | $-8M | |
| Stock Issued | $18M | $2M | $4M | $0 | $0 | $0 | $4M | $0 | $0 | $11M | $0 | $-1.0K | $-115.0K | $1M | $0 | $0 | |
| Net Stock Activity | · | $2M | · | · | · | $0 | · | · | · | $11M | · | · | · | · | · | · | |
| Financing Cash Flow | $18M | $3M | $4M | $277.0K | $6.0K | $468.0K | $4M | $244.0K | $132.0K | $12M | $-43.0K | $135M | $18M | $2M | $127.0K | $654.0K | |
| Net Change in Cash | $14M | $-303.0K | $1M | $-14M | $-4M | $13M | $-16M | $-6M | $-12M | $-2M | $-53M | $38M | $13M | $-6M | $-24M | $-30M | |
| Taxes Paid | · | · | · | · | · | · | · | $0 | · | · | $0 | $0 | · | · | $0 | $0 | |
| Free Cash Flow | · | $-27M | · | · | · | $-38M | · | · | · | $-39M | · | · | · | · | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1690.4% | -1096.4% | · | -1337.6% | -1784.0% | -1823.8% | · | -1889.2% | -1255.8% | -1893.9% | · | -61.8% | · | · | · | -803.4% | |
| Net Margin | -1619.9% | -1046.5% | · | -1253.3% | -2028.4% | -1699.6% | · | -1713.6% | -1088.2% | -1697.6% | · | -42.3% | · | · | · | -806.8% | |
| EBITDA Margin | -1690.4% | -1069.3% | · | -1337.6% | -1784.0% | -1774.2% | · | -1889.2% | -1255.8% | -1864.6% | · | -61.8% | · | · | · | -803.4% | |
| ROA | -13.4% | -11.9% | · | -10.2% | -18.2% | -11.8% | · | -8.6% | -10.4% | -10.9% | · | -2.3% | · | · | · | -6.2% | |
| ROE | -18.4% | -15.7% | · | -13.0% | -22.7% | -14.3% | · | -10.2% | -13.0% | -13.3% | · | -2.8% | · | · | · | -7.3% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.5 | 6.2 | · | 5.5 | 6.7 | 7.6 | · | 7.4 | 8.8 | 10.5 | · | 14.3 | · | · | · | 10.7 | |
| Quick Ratio | 1.5 | 0.6 | · | 0.4 | 0.9 | 1.0 | · | 1.0 | 1.2 | 1.7 | · | 4.3 | · | · | · | 2.9 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | · | · | · | 0.0 | |
| Receivables Turnover | 10.9 | 15.2 | · | 10.3 | 18.7 | 4.7 | · | 3.1 | 7.1 | 2.0 | · | 30.9 | · | · | · | 6.8 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.93 | $1.05 | · | $1.52 | $1.78 | $2.34 | · | $3.11 | $3.44 | $3.80 | · | $4.50 | · | · | · | $5.31 | |
| Revenue / Share | $0.01 | $0.03 | · | $0.02 | $0.03 | $0.03 | · | $0.02 | $0.04 | $0.03 | · | $0.28 | · | · | · | $0.05 | |
| Cash Flow / Share | · | $-0.28 | · | · | · | $-0.40 | · | · | · | $-0.42 | · | · | · | · | · | · | |
| Cash / Share | $0.25 | $0.12 | · | $0.12 | $0.27 | $0.32 | · | $0.35 | $0.42 | $0.55 | · | $1.18 | · | · | · | $1.35 | |
| EPS (TTM) | $-1.08 | $-1.42 | · | $-1.70 | $-1.78 | $-1.62 | · | $-1.58 | $-1.32 | $-1.38 | · | $-1.50 | $-1.82 | $-1.66 | · | $-1.11 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $10M | $11M | · | $9M | $9M | $10M | · | $11M | $33M | $33M | · | $35M | $15M | $14M | · | $13M | |
| Net Income TTM | $-103M | $-133M | · | $-157M | $-164M | $-148M | · | $-148M | $-123M | $-115M | · | $-95M | $-111M | $-100M | · | $-91M | |
| Market Cap | $187M | $184M | · | $218M | $117M | $85M | · | $177M | $148M | $464M | · | $423M | · | · | · | $643M | |
| P/E | -1.6 | -1.3 | · | -1.4 | -0.7 | -0.6 | · | -1.2 | -1.2 | -3.7 | · | -3.2 | -2.3 | -3.2 | · | -9.5 | |
| P/S | 18.6 | 16.4 | · | 23.4 | 12.9 | 8.6 | · | 15.5 | 4.5 | 13.9 | · | 12.2 | · | · | · | 50.6 | |
| P/B | 1.9 | 1.8 | · | 1.5 | 0.7 | 0.4 | · | 0.6 | 0.5 | 1.4 | · | 1.1 | · | · | · | 2.0 | |
| P / Tangible Book | 1.9 | 1.8 | · | 1.5 | 0.7 | 0.4 | · | 0.6 | 0.5 | 1.4 | · | 1.1 | 1.0 | 1.2 | · | 2.0 | |
| P / Cash Flow | · | -6.8 | · | · | · | -2.3 | · | · | · | -12.5 | · | · | · | · | · | · | |
| Earnings Yield | -61.4% | -74.7% | · | -73.0% | -141.3% | -177.4% | · | -80.6% | -80.5% | -26.9% | · | -31.4% | -42.8% | -31.3% | · | -10.5% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $11M | $10M | $34M | $14M | $10M |
| Betriebsgewinnmarge % | -1329.4% | -1667.2% | -336.6% | -768.2% | -697.8% |
| Nettoergebnis | $-148M | $-149M | $-102M | $-99M | $-67M |
| Verwässerte EPS | $-1.59 | $-1.65 | $-1.38 | $-1.64 | $-2.11 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 5.7 | 7.2 | 12.0 | 9.3 | 15.1 |
| Quick Ratio | 0.5 | 0.5 | 1.8 | 2.1 | 9.4 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-112M | $-143M | $-105M | $-97M | $-35M |
Institutionelle Eigentümer (13F) 148 Einreicher · $89.6M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
148
Gehaltener Wert
$89.6M
Neue Positionen
26
Geschlossene Positionen
22
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 26 (-4 vs. Vorquartal) | 22 (+11 vs. Vorquartal) | 45 (+14 vs. Vorquartal) | 28 (-10 vs. Vorquartal) | +10.5M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $13.755.883 | 7.815.843 | 15,36% | Aktien |
| Pfizer Inc | $7.879.924 | 4.690.431 | 8,80% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $7.407.080 | 4.208.568 | 8,27% | Aktien |
| VANGUARD GROUP INC | $6.843.676 | 4.304.198 | 7,64% | Aktien |
| MACKENZIE FINANCIAL CORP | $6.425.401 | 3.650.796 | 7,17% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $4.881.439 | 2.773.545 | 5,45% | Aktien |
| Kynam Capital Management, LP | $4.405.812 | 2.503.302 | 4,92% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $4.180.624 | 2.374.894 | 4,67% | Aktien |
| STATE STREET CORP | $2.873.929 | 1.632.914 | 3,21% | Aktien |
| BANK OF AMERICA CORP /DE/ | $2.483.287 | 1.410.958 | 2,77% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $1.841.451 | 1.046.279 | 2,06% | Aktien |
| TWO SIGMA ADVISERS, LP | $1.773.963 | 1.115.700 | 1,98% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $1.716.629 | 975.327 | 1,92% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.365.424 | 775.809 | 1,52% | Aktien |
| FMR LLC | $1.279.722 | 727.115 | 1,43% | Aktien |
| NORTHERN TRUST CORP | $1.254.819 | 712.965 | 1,40% | Aktien |
| MAVERICK CAPITAL LTD | $1.148.474 | 652.542 | 1,28% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.080.290 | 613.801 | 1,21% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.067.243 | 606.388 | 1,19% | Aktien |
| Qube Research & Technologies Ltd | $960.529 | 545.755 | 1,07% | Aktien |
| UBS Group AG | $910.573 | 517.371 | 1,02% | Aktien |
| 72 Investment Holdings, LLC | $834.358 | 474.067 | 0,93% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $723.323 | 410.979 | 0,81% | Aktien |
| MARSHALL WACE, LLP | $661.205 | 375.686 | 0,74% | Aktien |
| Green Alpha Advisors, LLC | $641.210 | 364.324 | 0,72% | Aktien |
| PFM Health Sciences, LP | $624.249 | 354.687 | 0,70% | Aktien |
| GOLDMAN SACHS GROUP INC | $568.260 | 322.875 | 0,63% | Aktien |
| Invesco Ltd. | $529.966 | 301.117 | 0,59% | Aktien |
| WELLS FARGO & COMPANY/MN | $525.035 | 298.315 | 0,59% | Aktien |
| XTX Topco Ltd | $473.716 | 269.157 | 0,53% | Aktien |
| Bruce & Co., Inc. | $440.000 | 250.000 | 0,49% | Aktien |
| Man Group plc | $422.516 | 240.066 | 0,47% | Aktien |
| Bank of New York Mellon Corp | $391.706 | 222.560 | 0,44% | Aktien |
| MILESTONE ASSET MANAGEMENT, LLC | $352.150 | 200.085 | 0,39% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $305.140 | 173.375 | 0,34% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $291.129 | 165.414 | 0,33% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $279.131 | 158.597 | 0,31% | Aktien |
| Graham Capital Management, L.P. | $274.409 | 155.914 | 0,31% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $247.421 | 140.580 | 0,28% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $232.320 | 132.000 | 0,26% | Aktien |
| Nuveen, LLC | $217.388 | 123.516 | 0,24% | Aktien |
| CITADEL ADVISORS LLC | $217.008 | 123.300 | 0,24% | Kaufoption |
| Cubist Systematic Strategies, LLC | $216.135 | 92.762 | 0,24% | Aktien |
| LPL Financial LLC | $216.082 | 122.774 | 0,24% | Aktien |
| MORGAN STANLEY | $213.523 | 121.320 | 0,24% | Aktien |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $206.800 | 117.500 | 0,23% | Aktien |
| DEUTSCHE BANK AG\ | $157.652 | 89.575 | 0,18% | Aktien |
| Quadrature Capital Ltd | $156.603 | 88.979 | 0,17% | Aktien |
| CANADA PENSION PLAN INVESTMENT BOARD | $142.736 | 81.100 | 0,16% | Aktien |
| Keystone Financial Group | $142.252 | 80.825 | 0,16% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| The City Canyon Family Trust dated May 31, 2021, Rachel E. Haurwitz, Felix Adler ×3 Einreichungen | 25. April 2025 | 5,00% | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 18 Insider · 9 Führungskräfte · 7 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Rachel E. Haurwitz | President and CEO | 20. Februar 2026 A | 447.150 | 0 | 0 | $0 |
| Sriram Ryali | Chief Financial Officer | 20. Februar 2026 A | 72.360 | 0 | 0 | $0 |
| Jason O'Byrne | Chief Financial Officer | 20. Februar 2024 A | 59.224 | 0 | 0 | $0 |
| Timothy P Kelly | Chief Technology Officer | 25. Februar 2026 S | 73.125 | 0 | 2 | $-18.188 |
| Tina M. Albertson | Chief Medical Officer | 20. Februar 2026 A | 68.523 | 0 | 1 | $-2.089 |
| Ruhi Ahmad Khan | Chief Business Officer | 20. Februar 2026 A | 104.998 | 0 | 1 | $-13.598 |
| Steven Kanner | Chief Scientific Officer | 20. Februar 2025 A | 431.556 | 0 | 0 | $0 |
| Ryan Fischesser | VP of Finance and Controller | 20. November 2024 A | 118.854 | 0 | 0 | $0 |
| Syed Ali-Aamir Rizvi | Chief Medical Officer | 21. Februar 2023 A | 59.373 | 0 | 0 | $0 |
| Dara Richardson-Heron | Direktor | 20. Februar 2026 A | · | 0 | 0 | $0 |
| Ran Zheng | Direktor | 20. Februar 2026 A | · | 0 | 0 | $0 |
| Nancy Whiting | Direktor | 20. Februar 2026 A | · | 0 | 0 | $0 |
| David Lee Johnson | Direktor | 20. Februar 2026 A | · | 0 | 0 | $0 |
| Natalie Sacks | Direktor | 20. Februar 2026 A | · | 0 | 0 | $0 |
| Scott Braunstein | Direktor | 20. Februar 2026 A | · | 0 | 0 | $0 |
| Barbara G Mcclung | · | 20. Februar 2026 A | 481.564 | 0 | 1 | $-13.598 |
| Andrew Guggenhime | · | 20. Februar 2026 A | · | 0 | 0 | $0 |
| FMR LLC | · | 27. Juli 2021 C | 1.464.775 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 15 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,08% | 164.575 SH | 2. Oktober 2026 | Täglich |
| IWC · iShares Trust | 0,03% | 319.257 SH | 11. September 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 79.869 SH | 19. August 2026 | Täglich |
| IBB · iShares Trust | 0,01% | 670.052 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,01% | 6.958 SH | 2. Oktober 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 131.852 SH | 2. Oktober 2026 | Täglich |
| RSSL · Global X Funds | 0,00% | 43.883 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 2.250.647 SH | 11. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,00% | 255.338 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 74.931 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 1.113.215 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3.013.973 SH | 19. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 524.917 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9.015 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 875.712 SH | 11. September 2026 | Täglich |
CRBU Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 13 Analysten
KAUF
Median-Ziel
$10.00
+719,7%
5 38,5%
Starker Kauf
7 53,8%
Kauf
1 7,7%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
7 Analysten · 2026-10-02Mittelwert-Ziel $11.86 +871,9%
← Unter allen Zielen
Aktueller Preis $1.22
Tief$4.00
Mittelwert$11.86
Hoch$32.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | · |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | · |
| OTLK | $57M | -0.6 | · | -4416.2% | 193.1% | 4.0% |
| FHTX | $306M | -4.6 | 36.8% | -240.3% | 80.2% | · |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | · |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | · |
| SPRB | $120M | -1.7 | -51.3% | · | -139.9% | · |
| TNYA | $154M | -1.2 | · | · | -81.2% | · |
| CBUS | · | -0.6 | -14.6% | -3492.3% | -223.0% | · |
| INO | $120M | -1.0 | -70.0% | -130000.0% | -322.8% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 13, 2026